|MDACC Study No:||2010-0317 (clinicaltrials.gov NCT No: NCT00878189)|
|Title:||A PHASE 1 TRIAL OF PF-03084014 IN PATIENTS WITH ADVANCED SOLID TUMOR MALIGNANCY AND T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA|
|Principal Investigator:||Guillermo Garcia-Manero|
|Study Description:||The goal of Part 1 of this clinical research study is to learn if PF-03084014 |
will have an effect on T-cell acute lymphoblastic leukemia or lymphoblastic
The goal of Part 2 of this study is to learn if PF-03084014 when given in
combination with dexamethasone will have an effect on T-cell acute
lymphoblastic leukemia or lymphoblastic leukemia.
The safety and tolerability of this PF-03084014 will be tests in both parts.